| Nome do produto |
Ondansetron hydrochloride dihydrate |
| Nome em inglês |
Ondansetron hydrochloride dihydrate; 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one hydrochloride dihydrate; ondansetron hydrochloride hydrate; carbazol-4-one dihydrate; odansetron hydrochloride dihydrate; 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one dihydrate hydrochloride; (+-)-2,3-dihydro-9-methyl-3-((2-methylimidazol-1-yl)methyl)carbazol-4(1h)-one monohydrochloride dihydrate; 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, monohydrochloride, (+-)-, dihydrate; ondansetron hcl dihydrate; 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one monohydrochloride; Ondansetron HCl; Zofran; Zofran ODT; Zophren; Zudan; 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate; 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride (1:1); 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide hydrochloride (1:1) |
| Fórmula molecular |
C18H25ClN4O |
| Peso Molecular |
348.8703 |
| InChI |
InChI=1/C18H24N4O.ClH/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17;/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23);1H/t12-,13+,14-; |
| CAS Registry Number |
103639-04-9;99614-01-4 |
| Estrutura Molecular |
|
| Ponto de ebuli??o |
553.1°C at 760 mmHg |
| O ponto de inflama??o |
288.3°C |
| Press?o de vapor |
1.47E-12mmHg at 25°C |
| Símbolos de perigo |
 T:Toxic;
|
| Códigos de risco |
R25:;
|
| Descri??o da Seguran?a |
S45:;
|
|
PT
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
RU
SA
TR
